Last edition
News about " Favipiravir (FaviventTM) to fight COVID-19"
Jenburkt Pharmaceuticals second in India to launch Favipiravir to fight COVID-19
Jenburkt Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name Favivent) for the treatment of mild to moderate COVID-19 symptoms at a price of Rs. 39/- per tablet
Favipiravir (FaviventTM) To Fight COVID-19 | 24/07/2020 | By Darshana | 447
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members